美股市場個股詳情

ANRO Alto Neuroscience

添加自選

14.160
+0.070+0.50%

收盤價 05/14 16:00 (美東)

14.200
+0.040+0.28%

盤後 16:00 (美東)

3.81億總市值-10488市盈率TTM

Alto Neuroscience股票討論區

登錄發表評論

Jaguar8

04/23 20:36

$Alto Neuroscience(ANRO.US)$
NEWS
Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
ALTO-101 demonstrated favorable pharmacokinetic and tolerability profile in Phase 1 study
Transdermal formulation provided significantly greater drug exposure with fewer adverse events
Proof-of-concept study for CIAS to start in the first half of 2024
Topline data expected in the second half of 2025
Achievement of target exposure with propri...

Moomoo AI

02/28 01:21

Investment firms see Alto Neuroscience's biomarker approach as a potential boost for clinical trials and patient outcomes. They predict a high stock risk/reward into 2H 2024/1H 2025 readouts, with a possible 100%-200% rise on positive data.